Mendota Financial Group’s Pfizer PFE Stock Holding History

Mendota Financial Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-101	Closed	-$2.56K	–	112
2025 Q1	$2.56K	Buy	+101	New	+$2.64K	﹤0.01%	101
2024 Q4	–	Sell	-10	Closed	-$290	–	939
2024 Q3	$290	Buy	+10	New	+$292	﹤0.01%	496
2023 Q2	–	Sell	-624	Closed	-$32.3K	–	357
2023 Q1	$32.3K	Sell	624 -16	-3%	-$691	0.03%	165
2022 Q4	$32.8K	Buy	+640	New	+$30.7K	0.04%	154

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Mendota Financial Group's PFE Position: Q2 2025 in Review

Mendota Financial Group sold out of Pfizer (PFE) in Q2 2025, closing a stake of 101 shares — an estimated $2.56K sold.

Mendota Financial Group first reported a position in PFE in Q4 2022 and held it in 4 quarters. The position peaked at $32.8K in Q4 2022. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

Mendota Financial Group reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
Mendota Financial Group sold 101 Pfizer shares in Q2 2025, an estimated $2.56K.
Mendota Financial Group first reported a position in Pfizer in Q4 2022 and held it in 4 quarters.
Mendota Financial Group's Pfizer position peaked at $32.8K in Q4 2022.
2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Mendota Financial Group's 13F filing for Q2 2025, filed 21 Jul 2025.